{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:17:27Z","timestamp":1787764647113,"version":"build-2784847793"},"reference-count":156,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis (TEN). The most common COVID-19 vaccination-related cutaneous manifestations are delayed local reactions, approximately 66% of which are associated with the Moderna vaccine, and 33% with the Pfizer vaccine. Aside from mild injection-site reactions, severe reactions include anaphylaxis and TEN. Most reactions, except for Stevens-Johnson syndrome and anaphylaxis, though unpredictable and unpreventable are mild and can be treated symptomatically. Findings from this review should allow primary care physicians and dermatologists to reach faster diagnosis and initiate prompt intervention.<\/jats:p>","DOI":"10.4103\/jfcm.jfcm_3_23","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T01:00:08Z","timestamp":1691024408000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review"],"prefix":"10.4103","volume":"30","author":[{"given":"Nouf F.","family":"Bin Rubaian","sequence":"first","affiliation":[{"name":"Department of Dermatology, King Fahad University Hospital, Al-Khobar, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Aljalfan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Fahad University Hospital, Al-Khobar, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serene R.","family":"Almuhaidib","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP:A registry-based study","volume":"86","author":"McMahon","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination:Review of world literature and own experience","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination:A registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2tx vaccination:A cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catal\u00e0","year":"2022","journal-title":"Br J Dermatol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1016\/j.jaip.2021.08.039","article-title":"COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema","volume":"9","author":"Fijen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/jdv.17343","article-title":"Cutaneous adverse reactions after m-RNA COVID-19 vaccine:Early reports from Northeast Italy","volume":"35","author":"Farinazzo","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1093\/milmed\/usab138","article-title":"Anaphylaxis after the COVID-19 vaccine in a patient with cholinergic urticaria","volume":"187","author":"Park","year":"2022","journal-title":"Mil Med"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/diseases9030058","article-title":"Skin adverse reactions to novel messenger RNA coronavirus vaccination:A case series","volume":"9","author":"Peigottu","year":"2021","journal-title":"Diseases"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1111\/jdv.17268","article-title":"Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 vaccine:An Italian single-centre case series","volume":"35","author":"Corbeddu","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7774\/cevr.2021.10.3.298","article-title":"Acute urticarial rash after COVID-19 vaccination containing polysorbate 80","volume":"10","author":"Burlando","year":"2021","journal-title":"Clin Exp Vaccine Res"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"507","DOI":"10.18176\/jiaci.0751","article-title":"Allergic reactions after administration of Pfizer-BioNTech COVID-19 vaccine to health care workers at a tertiary hospital","volume":"31","author":"Loli-Ausejo","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"e13683","DOI":"10.1111\/pai.13683","article-title":"Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2","volume":"33","author":"Rosa","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.anai.2021.07.020","article-title":"Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result","volume":"127","author":"Pitlick","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"e15093","DOI":"10.1111\/dth.15093","article-title":"COVID-19 vaccine-induced urticarial vasculitis","volume":"34","author":"Dash","year":"2021","journal-title":"Dermatol Ther"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamadermatol.2021.2474","article-title":"Association of facial pustular neutrophilic eruption with messenger RNA-1273 SARS-CoV-2 vaccine","volume":"157","author":"Merrill","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"524","DOI":"10.18176\/jiaci.0718","article-title":"Hypersensitivity to COVID-19 vaccine confirmed by a positive skin test result:A case report","volume":"31","author":"P\u00e9rez-Codesido","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1002\/jmv.27109","article-title":"Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine","volume":"93","author":"Abi","year":"2021","journal-title":"J Med Virol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.7326\/L21-0104","article-title":"Administration of a second dose of the Moderna COVID-19 vaccine after an immediate hypersensitivity reaction with the first dose:Two case reports","volume":"174","author":"Mustafa","year":"2021","journal-title":"Ann Intern Med"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.16516","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine \u2013United States, December 14-23,","volume":"21","author":"Shimabukuro","year":"2020","journal-title":"Am J Transplant"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/ajt.16517","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021","volume":"21","author":"Shimabukuro","year":"2021","journal-title":"Am J Transplant"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"R23-20240828","first-page":"e15490","article-title":"COVID-19 vaccination-induced rash:Does the choice of vaccine matter?","volume":"13","author":"Zafar","year":"2021","journal-title":"Cureus"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/ced.14673","article-title":"Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events:A case series of two patients","volume":"46","author":"Lam","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"ofab497","DOI":"10.1093\/ofid\/ofab497","article-title":"Delayed injection site reaction after mRNA-1273 vaccination in Japan:A retrospective, cross-sectional study","volume":"8","author":"Hibino","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ced.14856","article-title":"Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines:A 6-month retrospective study","volume":"47","author":"Papadimitriou","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.det.2021.05.016","article-title":"COVID-19 vaccines and the skin:The landscape of cutaneous vaccine reactions worldwide","volume":"39","author":"Sun","year":"2021","journal-title":"Dermatol Clin"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bjh.17530","article-title":"AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female","volume":"194","author":"Ryan","year":"2021","journal-title":"Br J Haematol"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/jdv.17757","article-title":"Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)","volume":"36","author":"Kim","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"e04947","DOI":"10.1002\/ccr3.4947","article-title":"Erythema multiforme major following sars-CoV-2 vaccine","volume":"9","author":"Saibene","year":"2021","journal-title":"Clin Case Rep"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1111\/jdv.17225","article-title":"Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination","volume":"35","author":"Gambichler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R33-20240828","first-page":"e466","article-title":"Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine","volume":"60","author":"Buj\u00e1n","year":"2021","journal-title":"Int J Dermatol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1111\/jdv.17495","article-title":"Erythema multiforme after CoronaVac vaccination","volume":"35","author":"Lopes","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/jdv.17688","article-title":"Nevocentric erythema multiforme after SARS-COV-2 vaccine","volume":"36","author":"Scharf","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/jdv.17682","article-title":"Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme","volume":"36","author":"Borg","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/jdv.17689","article-title":"Erythema multiforme after SARS-CoV-2 vaccine","volume":"36","author":"Zhang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R38-20240828","first-page":"77","article-title":"Viral-like reaction or hypersensitivity?Erythema multiforme minor reaction and moderate eosinophilia after the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 vaccine","volume":"32","author":"de","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00105-021-04911-4","article-title":"Erythema multiforme following COVID-19 vaccination (BNT162b2)","volume":"73","author":"Wunderlich","year":"2022","journal-title":"Hautarzt"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/medicina57080828","article-title":"Erythema multiforme and COVID-19:What do we know?","volume":"57","author":"Bennardo","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1111\/jdv.17221","article-title":"Lichen planus arising after COVID-19 vaccination","volume":"35","author":"Hiltun","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1111\/jdv.17718","article-title":"Development of oral lichen planus after COVID-19 vaccination \u2013A rare case report","volume":"36","author":"Sharda","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"R43-20240828","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/odi.14025","article-title":"Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26. COV2. S)","volume":"28","author":"Troeltzsch","year":"2022","journal-title":"Oral Dis"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/jdv.17687","article-title":"COVID vaccine-induced lichen planus on areas previously affected by vitiligo","volume":"36","author":"Piccolo","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1111\/jdv.17504","article-title":"New-onset cutaneous lichen planus triggered by COVID-19 vaccination","volume":"35","author":"Merhy","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"e15153","DOI":"10.1111\/dth.15153","article-title":"Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects:An observational study","volume":"34","author":"Grieco","year":"2021","journal-title":"Dermatol Ther"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"e15040","DOI":"10.1111\/dth.15040","article-title":"Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male","volume":"34","author":"Adya","year":"2021","journal-title":"Dermatol Ther"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1111\/jdv.17316","article-title":"Pityriasis rosea following CoronaVac COVID-19 vaccination:A case report","volume":"35","author":"Akda\u015f","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1111\/jdv.17301","article-title":"Pityriasis rosea, COVID-19 and vaccination:New keys to understand an old acquaintance","volume":"35","author":"Busto-Leis","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/jocd.14372","article-title":"Pityriasis rosea following SARS-CoV-2 vaccination:A case series","volume":"20","author":"Temiz","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R51-20240828","first-page":"431","article-title":"Pityriasis rosea as a possible complication of vaccination against COVID-19","volume":"118","author":"Dormann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"key":"R53-20240828","first-page":"e34","article-title":"Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination","volume":"185","author":"Carballido","year":"2021","journal-title":"Br J Dermatol"},{"key":"R54-20240828","first-page":"e721","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2021.10.055","article-title":"Pityriasis rosea shortly after mRNA-1273 COVID-19 Vaccination","volume":"114","author":"Shin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.27364","article-title":"Atypical pityriasis rosea associated with mRNA COVID-19 vaccine","volume":"94","author":"Bostan","year":"2022","journal-title":"J Med Virol"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"752443","DOI":"10.3389\/fmed.2021.752443","article-title":"Case report:Pityriasis rosea-like eruption following COVID-19 vaccination","volume":"8","author":"Leerunyakul","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"e15129","DOI":"10.1111\/dth.15129","article-title":"Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine:Case report and brief literature review","volume":"34","author":"Pedrazini","year":"2021","journal-title":"Dermatol Ther"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1111\/jdv.17502","article-title":"New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination","volume":"35","author":"Quattrini","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"e243173","DOI":"10.1136\/bcr-2021-243173","article-title":"Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine","volume":"14","author":"Torrealba-Acosta","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1002\/jmv.27175","article-title":"AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event:A case report","volume":"93","author":"Capassoni","year":"2021","journal-title":"J Med Virol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ced.14970","article-title":"Abrupt onset of sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme:Unravelling a possible common trigger, the COVID-19 vaccine","volume":"47","author":"Sechi","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/all.14981","article-title":"Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine","volume":"76","author":"Darrigade","year":"2021","journal-title":"Allergy"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"e246049","DOI":"10.1136\/bcr-2021-246049","article-title":"Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine","volume":"14","author":"Lee","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R65-20240828","first-page":"996","article-title":"Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)","volume":"138","author":"Paulsen","year":"2021","journal-title":"Blood"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1002\/ajh.26128","article-title":"Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine","volume":"96","author":"Toom","year":"2021","journal-title":"Am J Hematol"},{"key":"R67-20240828","first-page":"e14099","article-title":"Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 Vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID-19 vaccine","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/jth.15418","article-title":"First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination","volume":"19","author":"de","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R70-20240828","first-page":"419","article-title":"Evaluating the child with purpura","volume":"64","author":"Leung","year":"2001","journal-title":"Am Fam Physician"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"e245440","DOI":"10.1136\/bcr-2021-245440","article-title":"Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination","volume":"14","author":"Waraich","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R72-20240828","doi-asserted-by":"crossref","first-page":"e05032","DOI":"10.1002\/ccr3.5032","article-title":"Possible HSP reactivation post-COVID-19 vaccination and booster","volume":"9","author":"Kondo","year":"2021","journal-title":"Clin Case Rep"},{"key":"R73-20240828","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/vaccines9101078","article-title":"Henoch-sch\u00f6nlein purpura following the first dose of COVID-19 viral vector vaccine:A case report","volume":"9","author":"Sirufo","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R74-20240828","first-page":"2704249","article-title":"Immune thrombocytopenic purpura following administration of mRNA-Based SARS-CoV-2 and MMR vaccinations:A cautionary tale","volume":"2021","author":"Thomas","year":"2021","journal-title":"Case Rep Infect Dis"},{"key":"R75-20240828","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjd.20744","article-title":"A case of COVID-19 vaccination-associated forme fruste purpura fulminans","volume":"186","author":"Griss","year":"2022","journal-title":"Br J Dermatol"},{"key":"R76-20240828","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s42399-021-01025-9","article-title":"Arare case of henoch-sch\u00f6nlein purpura following a COVID-19 vaccine-case report","volume":"3","author":"Naitlho","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"R77-20240828","first-page":"e16871","article-title":"Immune thrombocytopenic purpura following Pfizer-BioNTech COVID-19 vaccine in an elderly female","volume":"13","author":"Jasaraj","year":"2021","journal-title":"Cureus"},{"key":"R78-20240828","doi-asserted-by":"crossref","first-page":"e04689","DOI":"10.1002\/ccr3.4689","article-title":"Immune thrombocytopenia in a 68-year-old woman after COVID-19 vaccination","volume":"9","author":"Kenney","year":"2021","journal-title":"Clin Case Rep"},{"key":"R79-20240828","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1111\/jog.14978","article-title":"Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination","volume":"47","author":"Bennett","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R80-20240828","first-page":"e16619","article-title":"Thrombotic thrombocytopenic purpura presentation in an elderly gentleman following COVID vaccine circumstances","volume":"13","author":"Chamarti","year":"2021","journal-title":"Cureus"},{"key":"R81-20240828","doi-asserted-by":"crossref","first-page":"31","DOI":"10.22551\/2021.31.0802.10182","article-title":"Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine","volume":"8","author":"Cooper","year":"2021","journal-title":"Arch Clin Cases"},{"key":"R82-20240828","first-page":"646","article-title":"Case report:Thrombotic thrombocytopenia after COVID-19 Janssen vaccination","volume":"103","author":"Costello","year":"2021","journal-title":"Am Fam Physician"},{"key":"R83-20240828","doi-asserted-by":"crossref","first-page":"ofab343","DOI":"10.1093\/ofid\/ofab343","article-title":"Acute immune thrombocytopenia (ITP) following COVID-19 vaccination in a patient with previously stable ITP","volume":"8","author":"Jawed","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R84-20240828","doi-asserted-by":"crossref","first-page":"e931478","DOI":"10.12659\/AJCR.931478","article-title":"A case of immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination","volume":"22","author":"King","year":"2021","journal-title":"Am J Case Rep"},{"key":"R85-20240828","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jha2.219","article-title":"Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine","volume":"2","author":"Al-Ahmad","year":"2021","journal-title":"EJHaem"},{"key":"R86-20240828","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjh.17613","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) \u2013A novel clinico-pathological entity with heterogeneous clinical presentations","volume":"195","author":"Lavin","year":"2021","journal-title":"Br J Haematol"},{"key":"R87-20240828","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/jth.15420","article-title":"Acquired thrombotic thrombocytopenic purpura:A rare disease associated with BNT162b2 vaccine","volume":"19","author":"Naitlho","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R88-20240828","first-page":"341","article-title":"Immune thrombocytopenia following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine","volume":"23","author":"Ganzel","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"R89-20240828","doi-asserted-by":"crossref","first-page":"e01245","DOI":"10.1016\/j.idcr.2021.e01245","article-title":"Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine","volume":"25","author":"Akiyama","year":"2021","journal-title":"IDCases"},{"key":"R90-20240828","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am J Hematol"},{"key":"R91-20240828","doi-asserted-by":"crossref","first-page":"e242678","DOI":"10.1136\/bcr-2021-242678","article-title":"Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine","volume":"14","author":"Hines","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R92-20240828","doi-asserted-by":"crossref","first-page":"e242220","DOI":"10.1136\/bcr-2021-242220","article-title":"Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination","volume":"14","author":"Fueyo-Rodriguez","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R93-20240828","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.annemergmed.2021.02.011","article-title":"Idiopathic thrombocytopenic purpura and the Moderna COVID-19 vaccine","volume":"77","author":"Julian","year":"2021","journal-title":"Ann Emerg Med"},{"key":"R94-20240828","doi-asserted-by":"crossref","first-page":"441.e3","DOI":"10.1016\/j.ajem.2021.05.001","article-title":"Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination","volume":"49","author":"Yocum","year":"2021","journal-title":"Am J Emerg Med"},{"key":"R95-20240828","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.17508","article-title":"Immune thrombocytopenic purpura after SARS-CoV-2 vaccine","volume":"194","author":"Candelli","year":"2021","journal-title":"Br J Haematol"},{"key":"R96-20240828","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1002\/ajh.26106","article-title":"Immune thrombocytopenia in a 22-year-old post COVID-19 vaccine","volume":"96","author":"Tarawneh","year":"2021","journal-title":"Am J Hematol"},{"key":"R97-20240828","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/JBM.S307047","article-title":"Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine","volume":"12","author":"Helms","year":"2021","journal-title":"J Blood Med"},{"key":"R98-20240828","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R99-20240828","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1136\/postgradmedj-2021-140947","article-title":"Acute immune thrombocytopenic purpura post first dose of COVID-19 vaccination","volume":"98","author":"Wong","year":"2022","journal-title":"Postgrad Med J"},{"key":"R100-20240828","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/jdv.17609","article-title":"Flagellate purpura associated with COVID-19 vaccination","volume":"36","author":"Heck","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R101-20240828","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/bjh.17782","article-title":"Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab","volume":"196","author":"Kirpalani","year":"2022","journal-title":"Br J Haematol"},{"key":"R102-20240828","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00277-021-04584-y","article-title":"Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine","volume":"101","author":"Ruhe","year":"2022","journal-title":"Ann Hematol"},{"key":"R103-20240828","doi-asserted-by":"crossref","first-page":"e2021047","DOI":"10.4084\/MJHID.2021.047","article-title":"Immune thrombocytopenic purpura cases following COVID-19 vaccination","volume":"13","author":"Condorelli","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R104-20240828","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.1111\/jdv.17497","article-title":"Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine","volume":"35","author":"Falkenhain-L\u00f3pez","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R105-20240828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11739-021-02778-w","article-title":"Immune thrombocytopenia following COVID-19 mRNA vaccine:Casuality or causality?","volume":"17","author":"Pasin","year":"2022","journal-title":"Intern Emerg Med"},{"key":"R106-20240828","first-page":"e626","article-title":"Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine","volume":"35","author":"Krajewski","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R107-20240828","doi-asserted-by":"crossref","first-page":"e15141","DOI":"10.1111\/dth.15141","article-title":"Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant)","volume":"34","author":"Sandhu","year":"2021","journal-title":"Dermatol Ther"},{"key":"R108-20240828","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1111\/jocd.14452","article-title":"Cutaneous small-vessel vasculitis following COVID-19 vaccine","volume":"20","author":"Kar","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R109-20240828","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1186\/s12879-021-06655-x","article-title":"First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2:A case report","volume":"21","author":"M\u00fccke","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R110-20240828","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ijd.15777","article-title":"New-onset leukocytoclastic vasculitis after COVID-19 vaccine","volume":"60","author":"Bostan","year":"2021","journal-title":"Int J Dermatol"},{"key":"R111-20240828","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/ijd.15623","article-title":"Leukocytoclastic vasculitis flare following the COVID-19 vaccine","volume":"60","author":"Cohen","year":"2021","journal-title":"Int J Dermatol"},{"key":"R112-20240828","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1016\/j.vaccine.2021.06.079","article-title":"Henoch-Sch\u00f6nlein purpura presenting post COVID-19 vaccination","volume":"39","author":"Hines","year":"2021","journal-title":"Vaccine"},{"key":"R113-20240828","first-page":"1","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination","volume":"2","author":"Pai","year":"2021","journal-title":"Science briefs of the Ontario COVID-19 science advisory table"},{"key":"R114-20240828","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2021.09.009","article-title":"Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine","volume":"17","author":"Ricardo","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R115-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2021.08.035","article-title":"Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine","volume":"17","author":"Perna","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R116-20240828","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1111\/jdv.17582","article-title":"Psoriasis exacerbation after COVID-19 vaccination:A report of 14 cases from a single centre","volume":"35","author":"Sotiriou","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R117-20240828","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/jdv.17690","article-title":"New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines:Two sides of the same coin?","volume":"36","author":"Pesqu\u00e9","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R118-20240828","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1111\/1346-8138.16137","article-title":"Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine","volume":"48","author":"Fang","year":"2021","journal-title":"J Dermatol"},{"key":"R119-20240828","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis:A brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"R120-20240828","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/ejhpharm-2021-002794","article-title":"Petechial skin rash associated with CoronaVac vaccination:First cutaneous side effect report before phase 3 results","volume":"30","author":"Cebeci","year":"2023","journal-title":"Eur J Hosp Pharm"},{"key":"R121-20240828","doi-asserted-by":"crossref","first-page":"100381","DOI":"10.1016\/j.bbih.2021.100381","article-title":"The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus","volume":"18","author":"Maldonado","year":"2021","journal-title":"Brain Behav Immun Health"},{"key":"R122-20240828","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7774\/cevr.2021.10.2.198","article-title":"A rare case of shingles after COVID-19 vaccine:Is it a possible adverse effect?","volume":"10","author":"Aksu","year":"2021","journal-title":"Clin Exp Vaccine Res"},{"key":"R123-20240828","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1002\/jmv.27036","article-title":"Herpes zoster emergence following mRNA COVID-19 vaccine","volume":"93","author":"Eid","year":"2021","journal-title":"J Med Virol"},{"key":"R124-20240828","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/jocd.14268","article-title":"Herpes zoster after inactivated COVID-19 vaccine:A cutaneous adverse effect of the vaccine","volume":"20","author":"Arora","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R125-20240828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/hcab208","article-title":"Herpes zoster following COVID-19 vaccine:A report of three cases","volume":"114","author":"Chiu","year":"2021","journal-title":"QJM"},{"key":"R126-20240828","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/jocd.14210","article-title":"20 post-COVID-19 vaccine-related shingles cases seen at the Las Vegas dermatology clinic and sent to us via social media","volume":"20","author":"Lee","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R127-20240828","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1111\/jdv.17422","article-title":"Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine","volume":"35","author":"Tessas","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R128-20240828","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination:Report of 5 cases","volume":"12","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R129-20240828","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/vaccines9060572","article-title":"Reactivation of varicella zoster virus after vaccination for SARS-CoV-2","volume":"9","author":"Psichogiou","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R130-20240828","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.17555","article-title":"Herpes zoster following SARS-CoV-2 vaccination \u2013A series of four cases","volume":"35","author":"Alpalh\u00e3o","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R131-20240828","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/jdv.17678","article-title":"Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine:Report of three cases from India","volume":"36","author":"Mehta","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R132-20240828","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/jocd.14035","article-title":"Herpes zoster following inactivated COVID-19 vaccine:A coexistence or coincidence?","volume":"20","author":"Bostan","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R133-20240828","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/vaccines9091013","article-title":"Varicella zoster virus reactivation following COVID-19 vaccination:A systematic review of case reports","volume":"9","author":"Katsikas","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R134-20240828","doi-asserted-by":"crossref","first-page":"e15146","DOI":"10.1111\/dth.15146","article-title":"Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female","volume":"34","author":"Majid","year":"2021","journal-title":"Dermatol Ther"},{"key":"R135-20240828","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1111\/jdv.17248","article-title":"Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"35","author":"Ackerman","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R136-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5070\/D3271052044","article-title":"Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine","volume":"27","author":"Jedlowski","year":"2021","journal-title":"Dermatol Online J"},{"key":"R137-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdermsci.2021.06.006","article-title":"Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations","volume":"103","author":"Ohsawa","year":"2021","journal-title":"J Dermatol Sci"},{"key":"R138-20240828","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/rheumatology\/keab702","article-title":"Comment on:Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases:A case series:Reply","volume":"61","author":"Furer","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R139-20240828","first-page":"e17215","article-title":"Toxic epidermal necrolysis post COVID-19 vaccination \u2013First reported case","volume":"13","author":"Bakir","year":"2021","journal-title":"Cureus"},{"key":"R140-20240828","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jop.13165","article-title":"Reported orofacial adverse effects of COVID-19 vaccines:The knowns and the unknowns","volume":"50","author":"Cirillo","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"R141-20240828","doi-asserted-by":"crossref","first-page":"e05099","DOI":"10.1002\/ccr3.5099","article-title":"Stevens-Johnson syndrome due to COVID-19 vaccination","volume":"9","author":"Mansouri","year":"2021","journal-title":"Clin Case Rep"},{"key":"R142-20240828","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ced.14784","article-title":"COVID-19 vaccine-induced Stevens-Johnson syndrome","volume":"46","author":"Dash","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R143-20240828","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.oooo.2021.06.019","article-title":"Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine:A case report","volume":"132","author":"Elboraey","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R144-20240828","first-page":"e9405","article-title":"Stevens-Johnson syndrome due to influenza vaccination","volume":"12","author":"Tong","year":"2020","journal-title":"Cureus"},{"key":"R145-20240828","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1111\/jocd.14459","article-title":"Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford\/AstraZeneca):A potential triggering factor?","volume":"20","author":"Essam","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R146-20240828","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000517256","article-title":"Darier's disease flare following COVID-19 vaccine","volume":"13","author":"Elb\u00e6k","year":"2021","journal-title":"Case Rep Dermatol"},{"key":"R147-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2021.11.023","article-title":"Alopecia areata after SARS-CoV-2 vaccination","volume":"20","author":"Scollan","year":"2022","journal-title":"JAAD Case Rep"},{"key":"R148-20240828","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/jocd.14581","article-title":"Recurrence of alopecia areata after COVID-19 vaccination:A report of three cases in Italy","volume":"20","author":"Rossi","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R149-20240828","doi-asserted-by":"crossref","first-page":"758354","DOI":"10.3389\/fmed.2021.758354","article-title":"Case report:Successful treatment of acute generalized exanthematous pustulosis with secukinumab","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R150-20240828","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3904\/kjim.2021.198","article-title":"COVID-19 vaccine-induced acute generalized exanthematous pustulosis","volume":"36","author":"Kang","year":"2021","journal-title":"Korean J Intern Med"},{"key":"R151-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdcr.2021.10.016","article-title":"Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine:A report of 2 cases","volume":"18","author":"Hai","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R152-20240828","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jdcr.2021.08.013","article-title":"Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine","volume":"16","author":"Agaronov","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R153-20240828","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1111\/1346-8138.16138","article-title":"Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis","volume":"48","author":"Wu","year":"2021","journal-title":"J Dermatol"},{"key":"R154-20240828","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdcr.2021.05.010","article-title":"A case of severe cutaneous adverse reaction following administration of the Janssen Ad26. COV2. S COVID-19 vaccine","volume":"13","author":"Lospinoso","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R155-20240828","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/jocd.14312","article-title":"Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination \u2013A case report","volume":"20","author":"Michon","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R156-20240828","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1111\/jdv.17633","article-title":"Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines","volume":"35","author":"Tihy","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of Family and Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfcm.jfcm_3_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:17:23Z","timestamp":1787761043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfcm.jfcm_3_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfcm.jfcm_3_23","relation":{},"ISSN":["2230-8229","2229-340X"],"issn-type":[{"value":"2230-8229","type":"print"},{"value":"2229-340X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-01-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}